Gertrude Biomedical

Peter van Bruchem Hardware & devices, Health & biotech
Company Owned Profile: No


Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

At Gertrude Biomedical our strategy is focused on modulating key gene 'switches' also known as transcription factors. This approach has the potential to identify novel therapeutics to treat diseases of unmet medical need.
Gertrude Biomedical is dedicated to developing novel small molecule inhibitors of the SOX18 transcription factor complex, targeting genes that build blood & lymphatic vessels. This approach 'short circuits' the gene programs that promote pathological vessels in disease, providing the potential to treat human diseases that depend on aberrant vasculature for their growth and spread.
Category: Hardware & devices, Health & biotech
URL: https://www.gertrudebiomed.com/
Operational Status:
ASX Listing Code (if applicable):
Year of Commencement: 2019
Address:

Level 6 12-20 Flinders Lane, Melbourne, Victoria 3000, AU
State: Victoria
Overseas Operations:
X:
Facebook:
Linkedin: https://linkedin.com/company/gertrude-biomedical
Founders:
No items found
Awards won: